Increased number of orexin/hypocretin neurons with high and prolonged external stress-induced depression

Behavioural Brain Research

Volumn 272, Issue , 2014, Pages 196-204

  Jalewa, Jaishree ^a,b   Wong Lin, KongFatt ^a   McGinnity, T Martin ^a   Prasad, Girijesh ^a   Hölscher, Christian ^a,b  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b LANCASTER UNIVERSITY   (United Kingdom)

Author keywords

Corticosterone; Depression; Motor activity; Orexin

Indexed keywords

CORTICOSTERONE; NEUROPEPTIDE; OREXINS; SIGNAL PEPTIDE;

ANIMAL; BODY WEIGHT; C57BL MOUSE; CELL COUNT; CIRCADIAN RHYTHM; DEPRESSION; DISEASE MODEL; LATERAL HYPOTHALAMUS; MALE; METABOLISM; MOTOR ACTIVITY; NERVE CELL; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; RANDOMIZATION;

ANIMALS; BODY WEIGHT; CELL COUNT; CIRCADIAN RHYTHM; CORTICOSTERONE; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; HYPOTHALAMIC AREA, LATERAL; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEURONS; NEUROPEPTIDES; NEUROPSYCHOLOGICAL TESTS; RANDOM ALLOCATION; STRESS, PHYSIOLOGICAL;

EID: 84904497805     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2014.05.030     Document Type: Article

References (73)

1. Drevets W.C., Price J.L., Furey M.L. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 2008, 213:93-118.
2. Lee S., Jeong J., Kwak Y., Park S.K. Depression research: where are we now?. Mol Brain 2010, 3:8.
3. Gmitrowicz A., Kucharska A. Developmental disorders in the fourth edition of the American classification: diagnostic and statistical manual of mental disorders (DSM IV - optional book). Psychiatr Pol 1994, 28:509-521.
4. Liu X., Buysse D.J., Gentzler A.L., Kiss E., Mayer L., Kapornai K., et al. Insomnia and hypersomnia associated with depressive phenomenology and comorbidity in childhood depression. Sleep 2007, 30:83-90.
5. Sateia M.J. Update on sleep and psychiatric disorders. Chest 2009, 135:1370-1379.
6. Emslie G.J., Kennard B.D., Mayes T.L., Nakonezny P.A., Zhu L., Tao R., et al. Insomnia moderates outcome of serotonin-selective reuptake inhibitor treatment in depressed youth. J Child Adolesc Psychopharmacol 2012, 22:21-28.
7. Tao R., Ma Z., McKenna J.T., Thakkar M.M., Winston S., Strecker R.E., et al. Differential effect of orexins (hypocretins) on serotonin release in the dorsal and median raphe nuclei of freely behaving rats. Neuroscience 2006, 141:1101-1105.
8. Pandi-Perumal S.R., Moscovitch A., Srinivasan V., Spence D.W., Cardinali D.P., Brown G.M. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine. Prog Neurobiol 2009, 88:264-271.
9. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA 1998, 95:322-327.
10. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998, 92:573-585.
11. Sakurai T. Reverse pharmacology of orexin: from an orphan GPCR to integrative physiology. Regul Pept 2005, 126:3-10.
12. Scammell T.E., Winrow C.J. Orexin receptors: pharmacology and therapeutic opportunities. Annu Rev Pharmacol Toxicol 2011, 51:243-266.
13. Urbanska A., Sokolowska P., Woldan-Tambor A., Bieganska K., Brix B., Johren O., et al. Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures. J Mol Neurosci 2012, 46:10-17.
14. Xu T.R., Ward R.J., Pediani J.D., Milligan G. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation. J Biol Chem 2012, 287:14937-14949.
15. Kukkonen J.P. Physiology of the orexinergic/hypocretinergic system: a revisit in. Am J Physiol Cell Physiol 2012, 2012.
16. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci 2007, 8:171-181.
17. Thannickal T.C. A decade of hypocretin/orexin: accomplishments in sleep medicine. Sleep Med Rev 2009, 13:5-8.
18. Mileykovskiy B.Y., Kiyashchenko L.I., Siegel J.M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 2005, 46:787-798.
19. Feng P., Vurbic D., Wu Z., Hu Y., Strohl K.P. Changes in brain orexin levels in a rat model of depression induced by neonatal administration of clomipramine. J Psychopharmacol 2008, 22:784-791.
20. Lopez M., Tena-Sempere M., Dieguez C. Cross-talk between orexins (hypocretins) and the neuroendocrine axes (hypothalamic-pituitary axes). Front Neuroendocrinol 2010, 31:113-127.
21. Sakurai T., Mieda M., Tsujino N. The orexin system: roles in sleep/wake regulation. Ann N Y Acad Sci 2010, 1200:149-161.
22. Joshi A., Wong-Lin K., McGinnity T.M., Prasad G. A mathematical model to explore the interdependence between the serotonin and orexin/hypocretin systems. Conf Proc IEEE Eng Med Biol Soc 2011, 2011:7270-7273.
23. Sakurai T., Mieda M. Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousal. Trends Pharmacol Sci 2011, 32:451-462.
24. Baldo B.A., Daniel R.A., Berridge C.W., Kelley A.E. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol 2003, 464:220-237.
25. Rainero I., Ostacoli L., Rubino E., Gallone S., Picci L.R., Fenoglio P., et al. Association between major mood disorders and the hypocretin receptor 1 gene. J Affect Disord 2011, 130:487-491.
26. Scott M.M., Marcus J.N., Pettersen A., Birnbaum S.G., Mochizuki T., Scammell T.E., et al. Hcrtr1 and 2 signaling differentially regulates depression-like behaviors. Behav Brain Res 2011, 222:289-294.
27. Jones D.N., Gartlon J., Parker F., Taylor S.G., Routledge C., Hemmati P., et al. Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity. Psychopharmacology (Berl) 2001, 153:210-218.
28. Kiwaki K., Kotz C.M., Wang C., Lanningham-Foster L., Levine J.A., Orexin A. (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats. Am J Physiol Endocrinol Metab 2004, 286:E551-E559.
29. Teske J.A., Levine A.S., Kuskowski M., Levine J.A., Kotz C.M. Elevated hypothalamic orexin signaling, sensitivity to orexin A, and spontaneous physical activity in obesity-resistant rats. Am J Physiol Regul Integr Comp Physiol 2006, 291:R889-R899.
30. Kotz C.M., Teske J.A., Levine J.A., Wang C. Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul Pept 2002, 104:27-32.
31. Takakusaki K., Takahashi K., Saitoh K., Harada H., Okumura T., Kayama Y., et al. Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy. J Physiol 2005, 568:1003-1020.
32. Zhang J., Li B., Yu L., He Y.C., Li H.Z., Zhu J.N., et al. A role for orexin in central vestibular motor control. Neuron 2011, 69:793-804.
33. Nestler E.J., Hyman S.E. Animal models of neuropsychiatric disorders. Nat Neurosci 2010, 13:1161-1169.
34. Micale V., Kucerova J., Sulcova A. Leading compounds for the validation of animal models of psychopathology. Cell Tissue Res 2013.
35. Liu W., Zhou C. Corticosterone reduces brain mitochondrial function and expression of mitofusin, BDNF in depression-like rodents regardless of exercise preconditioning. Psychoneuroendocrinology 2012, 37:1057-1070.
36. Murray F., Smith D.W., Hutson P.H. Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. Eur J Pharmacol 2008, 583:115-127.
37. Nollet M., Leman S. Role of orexin in the pathophysiology of depression: potential for pharmacological intervention. CNS Drugs 2013, 27:411-422.
38. Ito N., Yabe T., Nagai T., Oikawa T., Yamada H., Hanawa T. A possible mechanism underlying an antidepressive-like effect of Kososan, a Kampo medicine, via the hypothalamic orexinergic system in the stress-induced depression-like model mice. Biol Pharm Bull 2009, 32:1716-1722.
39. Nollet M., Gaillard P., Minier F., Tanti A., Belzung C., Leman S. Activation of orexin neurons in dorsomedial/perifornical hypothalamus and antidepressant reversal in a rodent model of depression. Neuropharmacology 2011, 61:336-346.
40. Mikrouli E., Wortwein G., Soylu R., Mathe A.A., Petersen A. Increased numbers of orexin/hypocretin neurons in a genetic rat depression model. Neuropeptides 2011, 45:401-406.
41. Zhao Y., Ma R., Shen J., Su H., Xing D., Du L. A mouse model of depression induced by repeated corticosterone injections. Eur J Pharmacol 2008, 581:113-120.
42. Porsolt R.D., Bertin A., Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Therapeut 1977, 229:327-336.
43. Steru L., Chermat R., Thierry B., Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985, 85:367-370.
44. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 1987, 92:180-185.
45. Allard J.S., Tizabi Y., Shaffery J.P., Trouth C.O., Manaye K. Stereological analysis of the hypothalamic hypocretin/orexin neurons in an animal model of depression. Neuropeptides 2004, 38:311-315.
46. West M.J., Slomianka L., Gundersen H.J. Unbiased stereological estimation of the total number of neurons in thesubdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991, 231:482-497.
47. Petersen A., Wortwein G., Gruber S.H., Mathe A.A. Escitalopram reduces increased hippocampal cytogenesis in a genetic rat depression model. Neurosci Lett 2008, 436:305-308.
48. Husum H., Aznar S., Hoyer-Hansen S., Larsen M.H., Mikkelsen J.D., Moller A., et al. Exacerbated loss of cell survival, neuropeptide Y-immunoreactive (IR) cells, and serotonin-IR fiber lengths in the dorsal hippocampus of the aged flinders sensitive line "depressed" rat: Implications for the pathophysiology of depression?. J Neurosci Res 2006, 84:1292-1302.
49. Adrien J. Neurobiological bases for the relation between sleep and depression. Sleep Med Rev 2002, 6:341-351.
50. Cowen P.J. Serotonin and depression: pathophysiological mechanism or marketing myth?. Trends Pharmacol Sci 2008, 29:433-436.
51. Fernstrom J.D., Fernstrom M.H. Exercise, serum free tryptophan, and central fatigue. J Nutr 2006, 136:553S-559S.
52. Jalewa J., Joshi A., McGinnity T.M., Prasad G., Wong-Lin K., Holscher C. Neural circuit interactions between the dorsal raphe nucleus and the lateral hypothalamus: an experimental and computational study. PloS One 2014, 9:e88003.
53. Rimer J., Dwan K., Lawlor D.A., Greig C.A., McMurdo M., Morley W., et al. Exercise for depression. Cochrane Database Syst Rev 2012, 7:CD004366.
54. Rethorst C.D., Sunderajan P., Greer T.L., Grannemann B.D., Nakonezny P.A., Carmody T.J., et al. Does exercise improve self-reported sleep quality in non-remitted major depressive disorder?. Psychol Med 2012, 1-11.
55. Herring M.P., Puetz T.W., O'Connor P.J., Dishman R.K. Effect of exercise training on depressive symptoms among patients with a chronic illness: a systematic review and meta-analysis of randomized controlled trials. Arch Intern Med 2012, 172:101-111.
56. Bao A.M., Meynen G., Swaab D.F. The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev 2008, 57:531-553.
57. Udden J., Bjorntorp P., Arner P., Barkeling B., Meurling L., Rossner S. Effects of glucocorticoids on leptin levels and eating behaviour in women. J Intern Med 2003, 253:225-231.
58. Solano J.M., Jacobson L. Glucocorticoids reverse leptin effects on food intake and body fat in mice without increasing NPY mRNA. Am J Physiol 1999, 277:E708-E716.
59. Moles A., Bartolomucci A., Garbugino L., Conti R., Caprioli A., Coccurello R., et al. Psychosocial stress affects energy balance in mice: modulation by social status. Psychoneuroendocrinology 2006, 31:623-633.
60. Foster M.T., Solomon M.B., Huhman K.L., Bartness T.J. Social defeat increases food intake, body mass, and adiposity in Syrian hamsters. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1284-R1293.
61. Coccurello R., D'Amato F.R., Moles A. Chronic social stress, hedonism and vulnerability to obesity: lessons from rodents. Neurosci Biobehav Rev 2009, 33:537-550.
62. Goodman E., Whitaker R.C. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 2002, 110:497-504.
63. Pan A., Sun Q., Czernichow S., Kivimaki M., Okereke O.I., Lucas M., et al. Bidirectional association between depression and obesity in middle-aged and older women. Int J Obes (Lond) 2012, 36:595-602.
64. Wong S.Y., Leung J.C., Leung P.C., Woo J. Depressive symptoms and change in abdominal obesity in the elderly: positive or negative association?. Am J Geriatr Psychiat 2011, 19:730-742.
65. Forman-Hoffman V.L., Yankey J.W., Hillis S.L., Wallace R.B., Wolinsky F.D. Weight and depressive symptoms in older adults: direction of influence?. J Gerontol B Psychol Sci Soc Sci 2007, 62:S43-S51.
66. de Wit L.M., van Straten A., van Herten M., Penninx B.W., Cuijpers P. Depression and body mass index, a u-shaped association. BMC Public Health 2009, 9:14.
67. Singh G., Jackson C.A., Dobson A., Mishra G.D. Bidirectional association between weight change and depression in mid-aged women: a population-based longitudinal study. Int J Obes (Lond) 2013.
68. Luppino F.S., de Wit L.M., Bouvy P.F., Stijnen T., Cuijpers P., Penninx B.W., et al. Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies. Arch Gen Psychiat 2010, 67:220-229.
69. de Wit L., Luppino F., van Straten A., Penninx B., Zitman F., Cuijpers P. Depression and obesity: a meta-analysis of community-based studies. Psychiatry Res 2010, 178:230-235.
70. Berridge C.W., Espana R.A., Vittoz N.M. Hypocretin/orexin in arousal and stress. Brain Res 2010, 1314:91-102.
71. Li Y., Li S., Sui N., Kirouac G.J. Orexin-A acts on the paraventricular nucleus of the midline thalamus to inhibit locomotor activity in rats. Pharmacol Biochem Behav 2009, 93:506-514.
72. Duxon M.S., Stretton J., Starr K., Jones D.N., Holland V., Riley G., et al. Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement. Psychopharmacology (Berl) 2001, 153:203-209.
73. Samson W.K., Bagley S.L., Ferguson A.V., White M.M. Orexin receptor subtype activation and locomotor behaviour in the rat. Acta Physiol (Oxf) 2010, 198:313-324.